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MiR-146a Upregulation of Phagocytosis in Human Macrophages
Sjögrens Syndrome (SjS) is an autoimmune disease that attacks exocrine glands such as salivary
and lacrimal glands resulting in severe dryness of the mouth and eyes. Previous studies have
linked increased microRNA-146a (miR-146a) expression in peripheral blood mononuclear cells in
SjS patients compared to healthy controls. MicroRNAs (miRNAs), small non-coding RNA
molecules that post-transcriptionally regulate gene expression, are known to play key regulatory
roles in immune responses and have been implicated in a growing number of autoimmune
disorders. Further investigation into the role of increased miR-146a expression in SjS revealed
links to several immune functions including phagocytosis.Our goal was to further examine the
relationship between miR-146a expression and the rate of phagocytosis in human macrophages
by using apoptotic human cells as a phagocytic target. We hypothesized that upregulation of miR146a would increase phagocytic activity of differentiated THP-1 human monocytes. To quantify
phagocytic activity, a pH-sensitive fluorescent dye (pHrodo) was used to indicate the E. coli or
apoptotic Jurkats that had been phagocytosed. THP-1 cells were transfected with miR-146a and
differentiated into macrophages. Phagocytic activity was observed by incubating fluorescently
labeled E.coli or apoptotic Jurkat cells with miR-146a transfected and mock transfected THP-1
cells for 2-4 hours. Fluorescence intensity was quantified using a fluorescent plate reader (E. coli)
and microscopy (apoptotic Jurkats). MiR-146a-transfected THP-1 cells exhibited significantly
increased phagocytic activity of fluorescently labeled E. coli (P<0.001) and apoptotic Jurkats.
Knockdown of TRAF6, a gene target of miR-146a, did not impact the phagocytic activity. MiR146a appears to upregulate phagocytic activity in human THP-1 cells through an unknown
mechanism. Further studies are in progress to determine the mechanism by which miR-146a
upregulates phagocytosis.

